Sunday, October 24, 2010: 6:30 PM
Sheraton Hall E/F (Sheraton Centre Toronto Hotel)
* Candidate for the Lee B. Lusted Student Prize Competition
Click here to view Poster Number Acronyms
Poster Board / Category
1
QMA
THE EFFECTS OF USING DIFFERENT PRIOR DISTRIBUTIONS FOR BETWEEN-STUDY VARIANCE ON OUTCOMES IN BAYESIAN RANDOM-EFFECTS META-ANALYSIS
Olga Gajic-Veljanoski1, Angela M. Cheung2, Ahmed M. Bayoumi3 and George Tomlinson1, (1)University of Toronto, Toronto, ON, Canada, (2)Osteoporosis Program, University Health Network, Toronto, ON, Canada, (3)Centre for Research on Inner City Health, the Keenan Research Centre in the Li Ka Shing Knowledge Institute, Toronto, ON, Canada
2
QMA
*
MODELING HISTORICAL TRENDS IN CERVICAL CANCER USING A MULTI-COHORT MODEL
Stephen Sy, BS, Jesse D. Ortendahl, BS, Sue J. Goldie, MD, MPH and Jane J. Kim, PhD, Harvard School of Public Health, Boston, MA
3
QMA
ELICITING PATIENTS' REVEALED PREFERENCES: AN INVERSE MARKOV DECISION PROCESS APPROACH
Zeynep Erkin, MS1, Matthew D. Bailey, PhD2, Lisa Maillart, PhD1, Andrew J. Schaefer, PhD1 and Mark S. Roberts, MD, MPP3, (1)University of Pittsburgh, Pittsburgh, PA, (2)Bucknell University, Lewisburg, PA, (3)University of Pittsburgh School of Medicine, Pittsburgh, PA
4
QMA
*
MEASURING THE BENEFIT OF PSA SCREENING FROM THE PATIENT AND SOCIETAL PERSPECTIVES
Jingyu Zhang, MS1, Brian T. Denton, PhD1, Nilay D. Shah, PhD2, Hari Balasubramanian, PhD3 and Brant Inman, MD4, (1)North Carolina State University, Raleigh, NC, (2)Mayo Clinic, Rochester, MN, (3)University of Massachusetts, Amherst, MA, (4)Duke University, Durham, NC
6
HSP
*
TESTING THE ACCURACY OF COMPOSITE HEALTH STATE UTILITY ESTIMATORS – AN ANALYSIS OF MEDICAL CONDITION PAIRS FROM MEPS 2001 AND 2003
Kim Rand-Hendriksen, Cand.Psychol1, Liv Ariane Augestad, MD1, Ivar Sønbø Kristiansen, MD, PhD2 and Knut Stavem1, (1)Akershus University Hospital, Lørenskog, Norway, (2)University of Oslo, Oslo, Norway
8
HSP
LEARNING EFFECTS IN EQ-5D TIME TRADE-OFF VALUATIONS
Liv Ariane Augestad, MD1, Kim Rand-Hendriksen, Cand.Psychol1, Ivar Sønbø Kristiansen, MD, PhD2 and Knut Stavem1, (1)Akershus University Hospital, Lørenskog, Norway, (2)University of Oslo, Oslo, Norway
10
HTA
HEALTH ECONOMIC EVALUATION OF ANTIPLATELET THERAPY IN THE SECONDARY PREVENTION OF STROKE
Vida Hamidi, Ph.D, Torbjørn Wisløff, M.Sc., Tove Ringerike, Ph.D, Ingrid Harboe and Marianne Klemp, MD, PhD, Norwegian Knowledge Centre for the Health Services, Oslo, Norway
11
HTA
COST-EFFECTIVENESS OF COMBINED INFLUENZA AND PNEUMOCOCCAL VACCINATION: IS IT THE RIGHT TIME?
Kenneth J. Smith, MD, MS, Bruce Y. Lee, MD, MBA, M. Patricia Nowalk, PhD, Mahlon Raymund, PhD and Richard K. Zimmerman, MD, MPH, University of Pittsburgh School of Medicine, Pittsburgh, PA
12
HTA
AN ECONOMIC ANALYSIS OF HEART AND STROKE FOUNDATION OF ONTARIO'S HYPERTENSION MANAGEMENT INITIATIVE (HMI)
Claire de Oliveira, PhD1, Harindra C. Wijeysundera, MD2, Sheldon Tobe, MD3, Margaret Moy Lum-Kwong, MBA4, Shirley Von Sychowski, MA4, Jack Tu, MD5 and Murray D. Krahn, MD, MSc6, (1)University Health Network, Toronto, ON, Canada, (2)Schulich Heart Center, Sunnybrook Health Sciences Center, Toronto, ON, Canada, (3)Division of Nephrology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, (4)Heart and Stroke Foundation of Ontario, Toronto, ON, Canada, (5)Institute for Clinical Evaluative Sciences, Toronto, CA, Canada, (6)University of Toronto, Toronto, ON, Canada
13
HTA
THE COST-EFFECTIVENESS OF GENETIC SCREENING IN NEONATAL DIABETES
Elbert S. Huang, MD, MPH1, Siri Atma W. Greeley, MD, PhD1, Priya John, MPH1, Aaron N. Winn, MPP2, Joseph Ornelas, MS1, Rebecca B. Lipton, PhD1, Graeme I. Bell, PhD1 and Louis H. Philipson, MD, PhD1, (1)University of Chicago, Chicago, IL, (2)Harvard, Cambridge, MA
14
HTA
THRESHOLDS FOR COST-EFFECTIVENESS OF ADDING AN AGENT THAT IMPROVES IMMUNE RESPONSES TO INITIAL ANTIRETROVIRAL THERAPY (ART) IN HIV-INFECTED PATIENTS: GUIDANCE FOR DRUG DEVELOPMENT
Bethany L. Morris1, Callie A. Scott, MSc1, Timothy Wilkin, MD2, Paul E. Sax, MD3, Roy M. Gulick, MD2, Kenneth A. Freedberg, MD, MSc1 and Bruce R. Schackman, PhD2, (1)Massachusetts General Hospital, Boston, MA, (2)Weill Cornell Medical College, New York, NY, (3)Brigham and Women's Hospital, Boston, MA
16
HTA
COST-EFFECTIVENESS OF NOVEL ANTIRETROVIRALS FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION
Ahmed M. Bayoumi, MD, MSc1, Vilija R. Joyce, MS2, Paul G. Barnett, PhD2, Susan Griffin, MSc, BSc3, Huiying Sun, PhD4, Gillian D. Sanders, PhD5, Nick J. Bansback, MSc4, Mark Holodniy, MD6, Sheldon T. Brown, MD7, Tassos C. Kyriakides, Ph.D.8, Mark Sculpher, PhD3, Aslam H. Anis, PhD9 and Douglas K. Owens, MD, MS10, (1)Centre for Research on Inner City Health, the Keenan Research Centre in the Li Ka Shing Knowledge Institute, Toronto, ON, Canada, (2)VA Palo Alto Health Care System, Menlo Park, CA, (3)University of York, York, United Kingdom, (4)St. Paul's Hospital, Vancouver, BC, Canada, (5)Duke, Durham, NC, (6)VA Palo Alto Health Care System, Palo Alto, CA, (7)Bronx VA Medical Center, Bronx, NY, (8)VA Connecticut Healthcare System, New Haven, CT, (9)University of British Columbia, Vancouver, BC, Canada, (10)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA
17
HTA
COST EFFECTIVENESS OF STOCKPILING PROTECTIVE FACEWEAR FOR AN INFLUENZA PANDEMIC
David W. Hutton, MS1, Nayer Khazeni, MD, MS1, Alan Garber, MD, PhD2 and Douglas K. Owens, MD, MS2, (1)Stanford University, Stanford, CA, (2)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA
18
HTA
*
COST-EFFECTIVE ALTERNATIVES TO LIVER BIOPSY IN THE MANAGEMENT OF CHRONIC HEPATITIS C
Shan Liu, S.M.1, Michael Schwarzinger, MD, PhD2, Fabrice Carrat, MD, PhD3 and Jeremy D. Goldhaber-Fiebert, PhD1, (1)Stanford University, Stanford, CA, (2)INSERM 912, Aix-Marseille University, Marseille, France, (3)INSERM U707, Pierre et Marie Curie University, Paris, France
19
HTA
A MODELED ECONOMIC EVALUATION OF ALTERNATIVE STRATEGIES TO REDUCE SUDDEN CARDIAC DEATH IN YOUNG ATHLETES
Michael Schoenbaum1, Benedetto Vitiello1, Peter Denchev, PhD1 and Jonathan Kaltman, MD2, (1)NIMH/NIH, Rockville, MD, (2)Nhlbi/NIH, Bethesda, MD
21
HSR
COST-EFFECTIVENESS IN CANADA OF RITUXIMAB FOR PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Denise Zou, MA1, Nancy Risebrough2, Oghenowede Eyawo, MSc1, Ron Goeree, MA3, Kevin Imrie, MD4, Fakher Aissa, MSc5, Rick Aultman, MSc6 and Adrian Levy, PhD7, (1)Oxford Outcomes, Vancouver, BC, Canada, (2)Oxford Outcomes, Toronto, ON, Canada, (3)McMaster University, Hamilton, ON, Canada, (4)University of Toronto, Toronto, ON, Canada, (5)Hoffmann-La Roche Canada, Mississauga, ON, Canada, (6)Hoffmann-La Roche, Basel, Switzerland, (7)Dalhousie University, Halifax, NS, Canada
22
HTA
THE COST-EFFECTIVENESS OF HEROIN ASSISTED TREATMENT FOR CHRONIC, TREATMENT-REFRACTORY OPIOID ADDICTS
Bohdan Nosyk, Ph.D.1, Evan Meikleham, M.Sc.2, Daphne P. Guh, M.Sc.2, Nick J. Bansback, MSc2, Eugenia Oviedo-Joekes, Ph.D.2, Suzanne Brissette, MD3, David C. Marsh, MD4, Martin T. Schechter, Md, Ph.D.5 and Aslam H. Anis, PhD5, (1)University of California, Los Angeles, Los Angeles, CA, (2)St. Paul's Hospital, Vancouver, BC, Canada, (3)Universite de Montreal, Montreal, QC, Canada, (4)Vancouver Coastal Health Authority, Vancouver, BC, Canada, (5)University of British Columbia, Vancouver, BC, Canada
23
DEM
*
DO DIAGNOSTIC REASONING FAULTS ALWAYS RESULT IN DIAGNOSTIC ERRORS OR PATIENT HARM?
Laura Zwaan, MSc1, Abel Thijs, MD, PhD2, Cordula Wagner, PhD3, Gerrit van der Wal, MD, PhD1 and Danielle R.M. Timmermans, PhD1, (1)EMGO Institute/ VU University Medical Center, Amsterdam, Netherlands, (2)Department of Internal Medicine, VU university medical center, Amsterdam, Netherlands, (3)NIVEL and VU University medical center, Utrecht, Netherlands
24
HSR
ATTITUDES OF EMERGENCY NURSES TOWARD THE DELIVERY OF SMOKING CESSATION COUNSELING
David Katz, MD, MSc1, Mark Vander Weg, PhD1, John Holman, MS2, Andrew Nugent, MD1, Laurence Baker, DO3 and Marita Titler, RN, PhD4, (1)University of Iowa Carver College of Medicine, Iowa City, IA, (2)Iowa City VA Medical Center, Iowa City, IA, (3)Iowa Methodist Medical Center, Des Moines, IA, (4)University of Michigan School of Nursing, Ann Arbor, MI
26
JDM
HIP AND KNEE OSTEOARTHRITIS: CAN DECISION AIDS INFLUNCE PATIENT TREATMENT CHOICE AND SATISFACTION WITH OUTCOMES?
Stephen Kearing, MS1, Kate F. Clay, MA, BSN2 and Ivan Tomek, MD2, (1)Dartmouth Medical School, Lebanon, NH, (2)Dartmouth Hitchcock Medical Center, Lebanon, NH
27
JDM
PROSTATE CANCER SCREENING CONTROVERSY: A CHALLENGE FOR DECISION AIDS FOR MEN AT HIGH RISK
Clement Gwede, PhD, MPH, RN, Shaenelle Wilson, MPH, Emmanuel Jean Francois, PhD, Susan Vadaparampil, PhD, Brian Rivers, PhD, DaoHai Yu, PhD, Cathy Meade, PhD, Randy Heysek, MD, Javier Torres-Roca, MD, Philippe Spiess, MD, Julio Pow-Sang, MD and Paul B. Jacobsen, PhD, Moffitt Cancer Center, Tampa, FL
28
JDM
DO MEN SCHEDULING A PROSTATE BIOPSY BENEFIT FROM INFORMATION ABOUT POTENTIAL TREATMENT OPTIONS?
Steven B. Zeliadt, PhD1, Laura Bonner, PhD1, Ranak Trivedi, PhD1, Carol Simons, BA1, Crystal Kimmie, BS1, Peggy Hannon, PhD, MPH2, Thuy Vu, MPH2, Chris Zipperer3, Michael Porter, MD1 and Dan Lin, MD1, (1)VA Puget Sound Healthcare System, Seattle, WA, (2)University of Washington, Seattle, WA, (3)Washington State Department of Health, Olympia, WA
30
JDM
PROMOTING USE OF PATIENT DECISION SUPPORT INTERVENTIONS IN A LARGE COMMUNITY-BASED MULTI-SPECIALTY GROUP PRACTICE
Grace A. Lin, MD, MAS1, Suepattra May, PhD, MPH2, Laurel Trujillo, MD3, Caroline Tietbohl, BA2, R. Adams Dudley, MD, MBA1 and Dominick Frosch, PhD2, (1)University of California, San Francisco, San Francisco, CA, (2)Palo Alto Medical Foundation Research Institute, Palo Alto, CA, (3)Palo Alto Medical Foundation, Palo Alto, CA
31
JDM
*
SHARED DECISION MAKING BEHAVIOURS IN FAMILY MEDICINE RESIDENTS
Marc-André Pellerin, B.A, B.Sc., M.Sc.-student1, Glyn Elwyn, MD, PhD2, Moira Stewart, MD, PhD3, Michel Labrecque, MD, PhD4, Mathieu Ouimet, Ph.D1, Michel Rousseau, Ph.D1, Dawn Stacey, PhD5, Dominick Frosch, PhD6, Trudy Van der Weijden, MD, PhD7, Jeremy Grimshaw, MBChB, PhD, FRCGP8, Hubert Robitaille, Ph.D9 and France Légaré, MD, PhD10, (1)Université Laval, Québec, QC, Canada, (2)Cardiff University, Cardiff, United Kingdom, (3)University of Western Ontario, London, ON, Canada, (4)Universite Laval, Quebec, QC, Canada, (5)University of Ottawa, Ottawa, ON, Canada, (6)Palo Alto Medical Foundation Research Institute, Palo Alto, CA, (7)Maastricht University, Maastricht, Netherlands, (8)Ottawa Health Research Institute, Ottawa, ON, Canada, (9)Research center of Centre hospitalier universitaire de Québec, Québec, QC, Canada, (10)CHUQ Research Center-Hospital St-François d'Assise, Knowledge Transfer and Health Technology Assessment, Quebec, QC, Canada
32
JDM
INFORMED CHOICE ON PAP SMEAR STILL LIMITED BY LACK OF KNOWLEDGE ON THE MEANING OF FALSE POSITIVE OR FALSE NEGATIVE TEST RESULTS
Ida J. Korfage, PhD1, Marjolein van Ballegooijen, MD, PhD1, Brendy Wauben, MSc2, Dik Habbema, PhD3 and Marie-Louise Essink-bot, MD, PhD4, (1)Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands, (2)Comprehensive Cancer Centre Limburg, Maastricht, Netherlands, (3)Erasmus MC, University Medical Center, Rotterdam, Netherlands, (4)Social Medicine, Amsterdam, Netherlands
33
JDM
THE IMPACT OF PATIENT-PHYSICIAN RELATIONSHIP COMPONENTS ON PHYSICIAN TRUST AND TREATMENT ADHERENCE IN PATIENTS WITH RHEUMATIC DISEASE
Sofia de Achaval, MS1, Michael A. Kallen, MPH, PhD1, Araceli Garcia-Gonzalez, MD1, Richard Street, PhD2 and Maria E. Suarez-Almazor, MD, PhD1, (1)The University of Texas M. D. Anderson Cancer Center, Houston, TX, (2)Texas A&M University, College Station, TX
34
JDM
UNDERLYING DIMENSIONS OF SATISFACTION WITH LABOR AND DELIVERY EXPERIENCE: AN EXPLORATORY FACTOR ANALYSIS
Anjali Kaimal, MD, MAS1, Sanae Nakagawa2, Kathryn Houston, MD, MA2, Erica Wu, MD2, Aaron B. Caughey, MD, MPP, MPH, PhD2 and Miriam Kuppermann, PhD, MPH2, (1)Massachusetts General Hospital, Harvard Medical School, Boston, MA, (2)University of California, San Francisco, CA
35
JDM
CLINICAL UNCERTAINTY AND RISK AVERSION ARE ASSOCIATED WITH PRIMARY CARE PROVIDER REFERRAL OF PATIENTS WITH SEVERE KIDNEY DISEASE TO NEPHROLOGY
Kellie Hunter Campbell, MD, MA1, Joshua Hemmerich, PhD1, Sandy G. Smith, PhD1, Chester Fox, MD2, James W. Mold, MD, MPH3, Marshall H. Chin, MD, MPH1 and William Dale, MD, PhD1, (1)University of Chicago, Chicago, IL, (2)University at Buffalo, Buffalo, NY, (3)University of Oklahoma, Oklahoma City, OK
37
JDM
IMPRECISE DEFINITIONS OF “PRECISE”: PREFERENCES FOR PRECISION DEPEND ON CONTEXT
Andrea Fuhrel-Forbis1, Brian J. Zikmund-Fisher, PhD1, Nicole Exe, MPH1, Valerie Kahn, MPH1, Holly Witteman, PhD2, Aleksandra Jankovic1, Andrea M. Angott, MS1 and Peter A. Ubel, MD3, (1)University of Michigan, Ann Arbor, MI, (2)University of Michigan, Toronto, ON, Canada, (3)VA Ann Arbor Healthcare System & University of Michigan, Ann Arbor, MI
38
JDM
A CROSS-SECTIONAL STUDY OF YOUNG ADULTS' RESPONSE TO MELANOMA RISK AND PREVENTION MESSAGES
Mary Politi, Ph.D.1, Erika A. Waters, PhD, MPH2, Meng-Ru Cheng, MSPH1 and Camilo Ruggero, Ph.D.3, (1)Washington University in St. Louis, St. Louis, MO, (2)Washington University School of Medicine, Saint Louis, MO, (3)University of North Texas, Denton, TX
40
HSR
*
DECISION MAKER PRIORITIES FOR PROVIDING ANTIRETROVIRAL THERAPY IN HIV-INFECTED SOUTH AFRICAN ADULTS: A QUALITATIVE ASSESSMENT
April D. Kimmel, PhD, MSc, Weill Cornell Medical College, New York, NY, Norman Daniels, Harvard School of Public Health, Boston, MA and Lisa Prosser, PhD, University of Michigan, Ann Arbor, MI
41
HSR
DO RESEARCH PAYMENTS INCREASE PERCEIVED COERCION? INITIAL RESULTS OF A NOVEL FINANCIAL INCENTIVE COERCION ASSESSMENT INSTRUMENT
Margaret M. Byrne, PhD1, Jason Croft, MBA2, Michael French, PhD1, Karen Dugosh, PhD2 and David Festinger, PhD2, (1)University of Miami, Miami, FL, (2)Treatment Research Institute, Philadelphia, PA
42
HTA
COMPOSITE CLINICAL ENDPOINTS: HANDLE WITH CARE?
Ellen Bohmer, MD, Sykehuset Innlandet Helseforetak, Brumunddal, Norway, Ivar Sønbø Kristiansen, MD, PhD, MPH, University of Oslo, Oslo, Norway and Sigrun Halvorsen, PhD, Ullevål University Hospital, Oslo, Norway
43
HTA
THE IMPACT OF TUMOR KINETIC GROWTH MODELS ON THE COST-EFFECTIVENESS OF PERIODIC SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA
Haku Ishida, M.D.1, John Wong, MD2, Isao Sakaida, M.D.3 and Yuji Inoue, M.D.1, (1)Yamaguchi University Hospital, Ube, Japan, (2)Tufts Medical Center, Boston, MA, (3)Yamaguchi University, School of Medicine, Ube, Japan
44
QMA
DEVELOPMENT OF PRIORITIES FOR ADVANCE CARE PLANNING AND END-OF-LIFE CARE IN CANADA
Ana P. Johnson, PhD, Queen's University, Kingston, ON, Canada and Daren K. Heyland, MD, Kingston General Hospital, Kingston, ON, Canada
45
HSR
THE IMPORTANCE OF FRAILTY WHEN CONSIDERING ANDROGEN-DEPRIVATION THERAPY FOR LOW-RISK BIOCHEMICAL RECURRENCE OF PROSTATE CANCER: A DECISION ANALYSIS
William Dale, MD, PhD1, Sara P. Bilir, MS1, Elbert S. Huang, MD, MPH1 and Supriya Mohile, MD, MA2, (1)University of Chicago, Chicago, IL, (2)University of Rochester, Rochester, NY
47
HSR
HOW ATTRACTIVE DOES A SET OF GUIDELINES HAVE TO BE TO WARRANT CORRECT ADOPTION AND UTILIZATION? THE USE AND MISUSE OF AN INFLUENTIAL SET OF GUIDELINES FOR USING COST-EFFECTIVENESS ANALYSIS
Sara Khor, MASc1, Dilfuza Djalalova, PhD2 and Jeffrey Hoch, PhD1, (1)Cancer Care Ontario, Toronto, ON, Canada, (2)St Michael's Hospital, Toronto, ON, Canada
48
HSR
*
THE OPTIMAL TIMING OF PREDIALYSIS PREARRANGED PAIRED KIDNEY EXCHANGES
Murat Kurt, MS, University of Pisttsburgh, Pittsburgh, PA, Andrew Schaefer, PhD, University of Pittsburgh, Pittsburgh, PA, M. Utku Unver, Ph.D., Boston College, Boston, MA and Mark S. Roberts, MD, MPP, University of Pittsburgh School of Medicine, Pittsburgh, PA
49
HSR
THE IMPACT OF SIMPLE PAPER-BASED TRIAGE SCALING TOOLS ON IMPROVING THE EFFECTIVENESS OF MULTIPLE DOMAINS CLINICAL PROTOCOLS FOR ADULT SURGICAL INTENSIVE CARE UNITS PATIENTS
Ying-Che Huang, MD1, Polun Chang, PhD1, Shih-pin Lin, MD2, Li-fen Wu, RN3, Huey-Wen Yien, MD, PhD4, Chia-yu Chou, MD5 and Kwok-Hon Chan, MD4, (1)Institute of Public Health and Biomedical informatics, National Yang-Ming University School of Medicine, Taipei, Taiwan, (2)Division of Biostatistics/Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan, (3)Taipei Veterans General Hospital Nursing Department, Taipei, Taiwan, (4)Department of Anesthesiology and Critical Care, Taipei Veterans General Hospital, Taipei, Taiwan, (5)Department of Critical care Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
50
HSR
THE DIAGNOSTIC ACCURACY AND COST-EFFECTIVENESS OF SEROLOGIC TESTS IN THE DIAGNOSIS OF CELIAC DISEASE
Vania Costa, MSc1, Kiran M. Chandra, MSc2, G. Blackhouse3, Bronwen McCurdy, B.Sc., MPH1, Luciano Ieraci, MSc4, Ron Goeree, MA3 and Leslie Levin, MD1, (1)Ontario Ministry of Health and Long-Term Care, Toronto, ON, Canada, (2)Ministry of Health and Long-Term Care / Programs for Assessment of Technology in Health Research Institute, Toronto, ON, Canada, (3)McMaster University, Hamilton, ON, Canada, (4)University of Toronto, Toronto, ON, Canada
51
HSR
THE ECONOMIC BURDEN OF ACUTE CARE HOSPITALIZATIONS FOR FRACTURES RELATED TO OSTEOPOROSIS IN CANADA
Jean-Eric Tarride, PhD, MA1, Robert Hopkins, MA1, William D. Leslie, MD, MSc2, Suzanne Morin, MD3, Matthias Bischof, MPharm, MSc, PhD1 and Ron Goeree, MA1, (1)McMaster University, Hamilton, ON, Canada, (2)University of Manitoba, Winnipeg, MB, Canada, (3)McGill University, Montreal, QC, Canada
52
HSR
THE APPLICATION OF POLICY DISEASE MODELS TO HEALTH CARE DECISION-MAKING IN DIABETES: FINDINGS FROM AN EVALUATION OF FOUR STRATEGIES FOR THE MANAGEMENT OF TYPE 2 DIABETES USING THE ONTARIO DIABETES ECONOMIC MODEL (ODEM)
Michelle Bornstein, MSc.1, Kiran M. Chandra, MSc.2, Gord Blackhouse, MSc.3, Kristen McMartin, Ph.D.1, Nicole Bradley, MHSc.1, Dawn Marvin, MSc.1, Leslie Levin, MD1, Daria J. O'Reilly, PhD, MSc4 and Ron Goeree, MA4, (1)Ministry of Health and Long-Term Care, Toronto, ON, Canada, (2)Ministry of Health and Long-Term Care / Programs for Assessment of Technology in Health Research Institute, Hamilton, Toronto, ON, Canada, (3)McMaster Unviersity, Hamilton, ON, Canada, (4)McMaster University, Hamilton, ON, Canada
54
HSP
A COMPARISON OF RATING AND CONJOINT ANALYSIS METHODS TO MEASURE CONSUMER PREFERENCES FOR HEARING AID ATTRIBUTES
John F.P. Bridges, PhD1, Angela T. Latalille, Au.D.2, Christine Buttorff, BA1, Sharon White, BA1 and John Niparko, M.D.3, (1)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (2)Johns Hopkins Medicine, Baltimore, MD, (3)Johns Hopkins School of Medicine, Baltimore, MD
56
HSR
ETHICAL AND RISK COMMUNICATION DILEMMAS FACED BY DECISION MAKERS DURING THE H1N1 2009 PANDEMIC: A MIXED METHODS ANALYSIS
A. Scott LaJoie, PhD, MSPH1, James J. Clark, PhD, LCSW2, Phyllis Leigh, MSW, CSW2, Miriam S. Silman, MSW2 and Ginny Sprang, PhD2, (1)University of Louisville, Louisville, KY, (2)University of Kentucky, Lexington, KY
